SCHEMBL1608463

SCHEMBL1608463

O=C(Cl)/C=C/c1ccc(Cl)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.72
MAOB P27338 7/20 0.58
HDAC2 Q92769 2/20 0.58
CXCL12 P48061 1/20 0.56
MAOA P21397 4/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPT P10636 2/20 0.55
NPC1 O15118 1/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HDAC1 Q13547 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
CYP1B1 Q16678 1/20 0.53
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC10 Q969S8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608460 1.00 CYP1A2 (0.72) CYP1A2MAOBHDAC2CXCL12MAOA
SCHEMBL2266594 0.91 CYP1A2 (0.56) CYP1A2MAOBHDAC2ALDH1A1MAPT
SCHEMBL2266597 0.91 CYP1A2 (0.56) CYP1A2MAOBHDAC2ALDH1A1MAPT
SCHEMBL5598994 0.84 CYP1A2 (1.00) CYP1A2MAOBHDAC2CXCL12MAOA
SCHEMBL5598991 0.84 CYP1A2 (1.00) CYP1A2MAOBHDAC2CXCL12MAOA
SCHEMBL28347012 0.84 CYP1A2 (0.75) CYP1A2MAOBHDAC2CXCL12MAOA
SCHEMBL11190484 0.82 KMT2A (0.50) CYP1A2MAOBHDAC2ALDH1A1MAPT
SCHEMBL2033989 0.82 TYR (0.68) MAOBHDAC2CXCL12MAPTLMNA
SCHEMBL126171 0.82 CYP1A2 (0.72) CYP1A2MAOBHDAC2CXCL12MAOA
SCHEMBL11190511 0.82 KMT2A (0.50) CYP1A2MAOBHDAC2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119184088-A Application of cinnamaldehyde oxime ester in bacterial wilt prevention and treatment 南京中医药大学翰林学院 2024-12-27 CN claimed
EP-4317225-B1 FLUORINE RESIN, COMPOSITION, PHOTOCROSSLINKED PRODUCT, AND ELECTRONIC DEVICE PROVIDED THEREWITH TOSOH CORP (JP) 2025-12-10 EP disclosed
US-20250263376-A1 (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY UNIWERSYTET JAGIELLONSKI (PL) 2025-08-21 US disclosed
CN-120118144-A Ursolic acid derivative, preparation method thereof and application thereof in glioma resistance 中国医学科学院药物研究所 2025-06-10 CN disclosed
CN-119899160-A Cinnamic acid-type phyllanthin A derivative and preparation method and application thereof 湖南化工职业技术学院 2025-04-29 CN disclosed
CN-119184088-A Application of cinnamaldehyde oxime ester in bacterial wilt prevention and treatment 南京中医药大学翰林学院 2024-12-27 CN disclosed
CN-118697737-A Application of piperlonguminine analogue compound in preparation of medicines for treating cervical cancer and/or liver cancer 赣南医学院第一附属医院 2024-09-27 CN disclosed
CN-116063263-B Quercetin benzene acrylic ester and preparation method and application thereof 安徽德信佳生物医药有限公司 2024-06-18 CN disclosed
US-20240182617-A1 FLUORINE RESIN, COMPOSITION, PHOTOCROSSLINKED PRODUCT, AND ELECTRONIC DEVICE PROVIDED THEREWITH TOSOH CORPORATION (JP) 2024-06-06 US disclosed
US-20240182422-A1 PREPARATION METHOD OF QUINOLINE DERIVATIVE COMPOUNDS ABIVAX (FR) 2024-06-06 US disclosed
US-4341718-A α-[(Alkylamino)-methyl]-β-aryloxy-benzeneethanols exhibiting antiarrhythmic activity AMERICAN HOME PRODUCTS CORPORATION (US) 1982-07-27 US disclosed
US-4335054-A Process for the preparation of alkenylbenzenecarboxylic acid derivatives and alkenylnaphthalenecarboxylic acid derivatives CIBA-GEIGY CORPORATION (US) 1982-06-15 US disclosed
US-4266066-A FROM CARBOXYLIC ACYL HALIDE AND ALUMINUM ALKYL COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1981-05-05 US disclosed
US-4264713-A COMPRISING LIGHT SENSITIVE POLYMERS OF AN UNSATURATED POLYESTER AND AN ACRYLIC POLYMER WITH UNSATURATED SIDE CHAINS FUJI PHOTO FILM CO., LTD. (JP) 1981-04-28 US disclosed
US-4151303-A Phenoxyalkylcarboxylic acid compounds and serum-lipid and triglyceride depressing therapeutic compositions BOEHRINGER MANNHEIM GMBH (DE) 1979-04-24 US disclosed
US-4014922-A CYCLOPROPYL SUBSTITUTED ESTERS; MITICIDES ZOECON CORPORATION (US) 1977-03-29 US disclosed
US-4010191-A Acyl derivatives of substituted bis-arylalkylamino compounds DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-03-01 US disclosed
US-3995054-A MITICIDES ZOECON CORPORATION (US) 1976-11-30 US disclosed
US-3975435-A BACTERIOSTATS GIVAUDAN CORPORATION (US) 1976-08-17 US disclosed
US-3948961-A CYCLOPROPYL ALKYL CARBOXYLATES, MITICIDE, INSECTICIDE ZOECON CORPORATION (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182422-A1 PREPARATION METHOD OF QUINOLINE DERIVATIVE COMPOUNDS NDUFB10, NDUFA10, H1-10 CYP1A2 134/4885MAOB 267/4885HDAC2 571/4885
US-20250263376-A1 (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY TYR, MITF, MC1R CYP1A2 3456/4885MAOB 100/4885HDAC2 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.